1 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
βGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
2PubMed Papers
18Diseases
0Drugs
0Pathogenic Variants
DATA QUALITYβ Swiss-Prot Reviewed
innate immune responseextracellular regionneurodegenerative diseasetrauma complicationsquamous cell carcinomahypertension
Based on limited published evidence, DEFB113 (defensin beta 113) is an antimicrobial peptide with antibacterial activity. DEFB113 is expressed in gingival tissues as part of the innate immune defense at mucosal sites 1. The gene shows age-related variations in expression levels in healthy gingival tissues and altered expression in periodontal disease states 1. DEFB113 contributes to the epithelial barrier's antimicrobial factor complement, supporting innate immunity at oral mucosal sites.
1
DEFB113 expression is altered across different age groups in gingival tissues and shows dynamic expression changes in response to periodontal disease, contributing to the antimicrobial defense transcriptome of oral mucosa
PMID: 35330821β Limited data available β This gene has 1 indexed publication. Summary and analysis may be incomplete.
neurodegenerative diseaseOpen Targets
trauma complicationOpen Targets
squamous cell carcinomaOpen Targets
ovarian neoplasmOpen Targets
benign chondrogenic neoplasmOpen Targets
muscular atrophyOpen Targets
Abruptio PlacentaeOpen Targets
glomerulonephritisOpen Targets
cardiovascular diseaseOpen Targets
metabolic syndromeOpen Targets
smoking initiationOpen Targets
corneal neovascularizationOpen Targets
Abnormal male internal genitalia morphologyOpen Targets
placenta praeviaOpen Targets
fungal infectious diseaseOpen Targets
No pathogenic variants reported on ClinVar for this gene.
No tissue expression data available for this gene.